Jana Steigerová

Statistics

Publications

Citations

204

H-Index

Active since

2010

Affiliations

Institute of Molecular and Translational Medicine(Current)

Palacký University Olomouc

Czech Academy of Sciences, Institute of Experimental Botany

Czech Academy of Sciences, Institute of Molecular Genetics

University Hospital Olomouc

Jana Steigerová is an author at Institute of Molecular and Translational Medicine specializing in life sciences, brassinosteroid biology, and pharmacology.

ORCID

Publications per year

2010–2018

Publications

Brassinosteroids cause cell cycle arrest and apoptosis of human breast cancer cells

Jana Steigerová, Jana Oklešťková, Monika Levková et al. · Chemico-Biological Interactions · 2010 · 77 citations

Life Sciences, Cancer Biology, Cell Biology +10

Mechanisms of natural brassinosteroid-induced apoptosis of prostate cancer cells

Jana Steigerová, Lucie Rárová, Jana Oklešťková et al. · Food and Chemical Toxicology · 2012 · 49 citations

Life Sciences, Cell Biology, Oncology +12

Structure activity relationship studies on cytotoxicity and the effects on steroid receptors of AB-functionalized cholestanes

Lucie Rárová, Jana Steigerová, Miroslav Kvasnica et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2016 · 34 citations · Full text

Life Sciences, Biochemistry, Pharmacology +11

Targeting genotoxic and proteotoxic stress‐response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram

Dušana Majera, Zdeněk Škrott, Jan Bouchal et al. · The Prostate · 2018 · 32 citations

Medicine, Oncology, Pharmacology +16

The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitro

Lucie Rárová, David Sedlák, Jana Oklešťková et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2018 · 12 citations

Medicine, Oncology, Pharmacology +11

1–5 of 5